NWK Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

NWK Group’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-31	Closed	-$1K	–	267
2020 Q2	$1K	Buy	+31	New	+$407	﹤0.01%	253

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

NWK Group's CVET Position: Q3 2020 in Review

NWK Group sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2020, closing a stake of 31 shares — an estimated $1K sold.

NWK Group first reported a position in CVET in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 269 funds tracked by Wall St. Rank hold CVET as of Q3 2020.

NWK Group reported no remaining Covetrus, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
NWK Group sold 31 Covetrus, Inc. Common Stock shares in Q3 2020, an estimated $1K.
NWK Group first reported a position in Covetrus, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
NWK Group's Covetrus, Inc. Common Stock position peaked at $1K in Q2 2020.
269 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2020.

Based on NWK Group's 13F filing for Q3 2020, filed 16 Nov 2020.